In this retrospective study of carefully selected patients with myelitis associated with rheumatologic disease (unrelated to typical MS), we found that nearly half had AQP4-IgG seropositive NMOSD while a small but clinically significant proportion had MOGAD. Here, AQP4 is linked to myeloid sarcoma.